Matches in Wikidata for { <http://www.wikidata.org/entity/Q92452730> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q92452730 description "artículu científicu espublizáu n'agostu de 2019" @default.
- Q92452730 description "scientific article published on 03 August 2019" @default.
- Q92452730 description "wetenschappelijk artikel" @default.
- Q92452730 description "наукова стаття, опублікована 3 серпня 2019" @default.
- Q92452730 name "Enhancing the physical stability and supersaturation generation of amorphous drug-polyelectrolyte nanoparticle complex via incorporation of crystallization inhibitor at the nanoparticle formation step: A case of HPMC versus PVP" @default.
- Q92452730 name "Enhancing the physical stability and supersaturation generation of amorphous drug-polyelectrolyte nanoparticle complex via incorporation of crystallization inhibitor at the nanoparticle formation step: A case of HPMC versus PVP" @default.
- Q92452730 type Item @default.
- Q92452730 label "Enhancing the physical stability and supersaturation generation of amorphous drug-polyelectrolyte nanoparticle complex via incorporation of crystallization inhibitor at the nanoparticle formation step: A case of HPMC versus PVP" @default.
- Q92452730 label "Enhancing the physical stability and supersaturation generation of amorphous drug-polyelectrolyte nanoparticle complex via incorporation of crystallization inhibitor at the nanoparticle formation step: A case of HPMC versus PVP" @default.
- Q92452730 prefLabel "Enhancing the physical stability and supersaturation generation of amorphous drug-polyelectrolyte nanoparticle complex via incorporation of crystallization inhibitor at the nanoparticle formation step: A case of HPMC versus PVP" @default.
- Q92452730 prefLabel "Enhancing the physical stability and supersaturation generation of amorphous drug-polyelectrolyte nanoparticle complex via incorporation of crystallization inhibitor at the nanoparticle formation step: A case of HPMC versus PVP" @default.
- Q92452730 P1433 Q92452730-FC99022F-91CA-4BE2-ACFF-B7022C239E7F @default.
- Q92452730 P1476 Q92452730-D3FF2122-5544-4BD2-BA28-4190DC8F2BE0 @default.
- Q92452730 P2093 Q92452730-9CC1F7C8-16D6-4151-B70B-85B7A16D1A41 @default.
- Q92452730 P2093 Q92452730-AD4C99E1-BD59-4380-991B-A78A469FBD31 @default.
- Q92452730 P304 Q92452730-98CAED70-EAE1-46F3-892B-E983B366521A @default.
- Q92452730 P31 Q92452730-0724A2CD-2711-441B-9833-42C47849E2EF @default.
- Q92452730 P356 Q92452730-76A16E1A-9BB3-4CD5-BCF6-9CF2436E3640 @default.
- Q92452730 P478 Q92452730-6586D76A-E7E0-434B-92CC-7B52A01C2C9D @default.
- Q92452730 P50 Q92452730-98B97203-6F74-4A08-88CD-DF8CF4B21507 @default.
- Q92452730 P577 Q92452730-B369DC58-2D62-4ED4-B1B7-2C32890E0838 @default.
- Q92452730 P698 Q92452730-BEF25685-7BD3-4CC5-90E0-2D3450EFDF8B @default.
- Q92452730 P921 Q92452730-6A1BECDB-A180-4AC5-9B9B-A520CDC4FA83 @default.
- Q92452730 P921 Q92452730-F6D34DA0-0EEB-42CC-80EA-D632C8C1420B @default.
- Q92452730 P356 J.EJPS.2019.105035 @default.
- Q92452730 P698 31386892 @default.
- Q92452730 P1433 Q5412738 @default.
- Q92452730 P1476 "Enhancing the physical stability and supersaturation generation of amorphous drug-polyelectrolyte nanoparticle complex via incorporation of crystallization inhibitor at the nanoparticle formation step: A case of HPMC versus PVP" @default.
- Q92452730 P2093 "Bingxue Dong" @default.
- Q92452730 P2093 "Li Ming Lim" @default.
- Q92452730 P304 "105035" @default.
- Q92452730 P31 Q13442814 @default.
- Q92452730 P356 "10.1016/J.EJPS.2019.105035" @default.
- Q92452730 P478 "138" @default.
- Q92452730 P50 Q84084005 @default.
- Q92452730 P577 "2019-08-03T00:00:00Z" @default.
- Q92452730 P698 "31386892" @default.
- Q92452730 P921 Q61231 @default.
- Q92452730 P921 Q901016 @default.